Table 3.
Estimated prices for a full antimalarial treatment at participating outlets.
| Medicine | Median price, USha (range) | Median price, USDa (range) | Response rateb |
|---|---|---|---|
| ACT | |||
| Coartem | 1,500 (1,200–15,000) |
0.54 (0.43–5.39) |
55.0% |
| Falcimon Kit | 10,000 | 3.60 | |
| Artenum® | 4,000 | 1.44 | |
| Nonartemisinin therapies | |||
| Quinine syrup | 3,000 (2,000–4,000) |
1.08 (0.72–1.44) |
67.6% |
| Quinine tablets | 2,500 (1,000–5,000) |
0.90 (0.36–1.80) |
|
| Quinine injection | 3,000 (1000–4000) |
1.08 (0.36–1.44) |
25.0% |
| Chloroquine | 2,500 (1,500–3,000) |
0.90 (0.54–1.08) |
40.9% |
| Fansidar® | 1,500 (1,500–3,000) |
0.54 (0.54–1.08) |
25.6% |
aPrice reflects full course treatment. In instances where only the price per tablet was shared, this price was used to calculate the price for a full course of treatment based on clinical guidelines. bThe proportion of those vendors who both carried the respective antimalarial medicine and were willing to share what they charged their customers.